A fibroid that gets very big can distort the inside and the outside of the uterus
ELIXA trial included patients with recent cardiovascular event (patients with acute coronary syndrome 180 days before randomization), and although there was no benefit in MACE reduction in lixisenatide treated patients compared to placebo, results revealed cardiovascular safety of lixisenatide in this specific high risk population (38, 40)
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, representing a related but distinct medication class
Theriogenology (2000) 54:77186
Though not dangerous, these symptoms can be uncomfortable and may persist with continued high-dose usage
Helps maintain immune and mitochondrial health*1,4,6-9